Historical development of bipolar coagulation
Related Experiment Video
Updated: Jun 8, 2026

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
Published on: August 4, 2023
Stephen L Barrett1, Joseph M Vella, A Lee Dellon
1Midwestern University College of Health Services, Arizona Pediatric Medicine Program, Glendale, AZ, USA. slbarrettpod@me.com
Abstract:
In 1926, a physicist at Harvard named William T. Bovie created an instrument, which revolutionized the medical profession--the unipolar electrocautery device. This incredible device could make surgical incisions and provide hemostasis as well. It came with a price, however, as it also created new risks and dangers in the operating room, such as electrical burns and fires. To resolve some of these problems, a bipolar electrocautery device was developed. The historical development and principles of both unipolar and bipolar electrocautery will be discussed in this article.
Related Concept Videos
Bipolar Disorder
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

